Month: February 2024

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million

TORONTO, ON / ACCESSWIRE / February 6, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...

Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain

First study ever to evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer...

IRLAB’s Pioneering Phase IIb Study with Pirepemat – React-PD – Provides New Insights in Specific Parkinson’s Patient Population and Enables a Data Driven Prediction of Study Timelines

GOTHENBURG, SWEDEN / ACCESSWIRE / February 6, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 6, 2024 - IRLAB Therapeutics...

Iodine Software Introduces AwareUM, a New Solution That Helps Hospitals Streamline Utilization Management and Strengthen Revenue Integrity

Built on Iodine's industry-leading CognitiveML engine, AwareUM emulates clinical thinking to improve productivity and meet medical necessity requirementsAUSTIN, TX /...

Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics’ AI-Driven Epigenetic-Genetic Heart Disease Tests

resTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease testsCHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings,...

error: Content is protected !!